KISS1 over-expression suppresses metastasis of pancreatic adenocarcinoma in a xenograft mouse model

详细信息    查看全文

• 作者：Lacey R. McNally (1)
  Danny R. Welch (10) (11) (2) (3) (4) (7) (9)
  Benjamin H. Beck (2)
  Lewis J. Stafford (2)
  Joshua W. Long (5)
  Jeffery C. Sellers (1)
  Zhi Q. Huang (1)
  William E. Grizzle (2) (7) (8) (9)
  Cecil R. Stockard (2)
  Kevin T. Nash (2)
  Donald J. Buchsbaum (1) (10) (2) (4) (5) (6) (7)
  
• 关键词：KISS1 ; Metastasis suppressor ; Pancreatic adenocarcinoma
• 刊名：Clinical & Experimental Metastasis
• 出版年：2010
• 出版时间：December 2010
• 年：2010
• 卷：27
• 期：8
• 页码：591-600
• 全文大小：794KB
• 参考文献：1. Hezel AF, Kimmelman AC, Stanger B, Bardeesy N, DePinho RA (2006) Genetics and biology of pancreatic ductal adenocarcinoma. Genes Develop 20:1218-249 CrossRef
  2. Wray CJ, Ahmad SA, Matthews JB, Lowy AM (2005) Surgery for pancreatic cancer: recent controversies and current practice. Gastroenterology 128:1626-641 CrossRef
  3. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59:225-49 CrossRef
  4. Breslin TM et al (2001) Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration. Ann Surg Oncol 8:123-32 CrossRef
  5. Stathopoulos GP, Androulakis N, Souglakos J, Stathopoulos J, Georgoulias V (2008) Present treatment and future expectations in advanced pancreatic cancer. Anticancer Res 28:1303-308
  6. Rinker-Schaeffer CW, O’Keefe JP, Welch DR, Theodorescu D (2006) Metastasis suppressor proteins: discovery, molecular mechanisms, and clinical application. Clin Cancer Res 12:3882-889 CrossRef
  7. Chirco R, Liu XW, Jung KK, Kim HR (2006) Novel functions of TIMPs in cell signaling. Cancer Metastasis Rev 25:99-13 CrossRef
  8. Freije JM, MacDonald NJ, Steeg PS (1998) Nm23 and tumour metastasis: basic and translational advances. Biochem Soc Symposia 63:261-71
  9. Stafford LJ, Vaidya KS, Welch DR (2008) Metastasis suppressors genes in cancer. Int J Biochem Cell Biol 40:874-91 CrossRef
  10. Steeg PS (2003) Metastasis suppressors alter the signal transduction of cancer cells. Nat Rev Cancer 3:55-3 CrossRef
  11. Jiang Y, Berk M, Singh LS, Tan HY, Yin LH, Powell CT et al (2005) KISS1 suppresses metastasis in human ovarian cancer via inhibition of protein kinase C alpha. Clin Exp Metastasis 22:369-76 CrossRef
  12. Stafford LJ, Xia CZ, Ma WB, Cai Y, Liu MY (2002) Identification and characterization of mouse metastasis-suppressor KISS1 and its G-protein-coupled receptor. Cancer Res 62:5399-404
  13. Masui T, Doi R, Mori T et al (2004) Metastin and its variant forms suppress migration of pancreatic cancer cells. Biochem Biophys Res Commun 315:85-2 CrossRef
  14. Nagai K, Doi R, Katagiri F, Ito T, Kida A, Koizumi M, Masui T, Kawaguchi Y, Tomita K, Oishi S, Fujii N, Uemoto S (2009) Prognostic value of metastin expression in human pancreatic cancer. J Exp Clin Cancer Res 21:28-9
  15. Katagiri F, Nagai K, Kida A, Tomita K, Oishi S, Takeyama M, Doi R, Fujii N (2009) Clinical significance of plasma metastin level in pancreatic cancer patients. Oncol Rep 21:815-19
  16. Akisawa N, Nishimori I, Iwamura T, Onishi S, Hollingsworth MA (1999) High levels of ezrin expressed by human pancreatic adenocarcinoma cell lines with high metastatic potential. Biochem Biophys Res Commun 258:395-00 CrossRef
  17. Kitamura N, Iwamura T, Taniguchi S, Yamanari H, Kawano K, Holli SR, Bramhall J, Schulz J, Nemunaitis PD, Brown BailletM, Buckels JA (2002) A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer. Br J Cancer 87:161-67 CrossRef
  18. Hollingsworth MA, Setoguchi T (2001) High collagenolytic activity in spontaneously highly metastatic variants derived from a human pancreatic cancer cell line (SUIT-2) in nude mice. Clin Exp Met 18:561-71
  19. Nash KT, Phadke PA, Navenot JM, Hurst DR, Accavitti-Loper MA, Sztul E, Vaidya KS, Frost AR, Kappes JC, Peiper SC, Welch DR (2007) Requirement of KISS1 secretion for multiple organ metastasis suppression and maintenance of tumor dormancy. J Natl Cancer Inst 99:309-21 CrossRef
  20. Johnson MR, Wang K, Smith JB, Heslin MJ, Diasio RB (2000) Quantitation of dihydropyrimidine dehydrogenase expression by real-time reverse transcription polymerase chain reaction. Anal Biochem 278:175-84 CrossRef
  21. DeRosier LC, Buchsbaum DJ, Oliver PG, Huang ZQ, Sellers JC, Grizzle WE, Wang W, Zhou T, Zinn KR, Long JW, Vickers SM (2007) Combination treatment with TRA-8 anti death receptor 5 antibody and CPT-11 induces tumor regression in an orthotopic model of pancreatic cancer. Clin Cancer Res 13:5535s-543s CrossRef
  22. Longo R, Cacciamani F, Naso G, Gasparini G (2008) Pancreatic cancer: from molecular signature to target therapy. Crit Rev Oncol Hematol 68:197-11 CrossRef
  23. Dhar DK, Naora H, Kubota H, Maruyama R, Yoshimura H, Tonomoto Y et al (2004) Downregulation of KiSS-1 expression is responsible for tumor invasion and worse prognosis in gastric carcinoma. Int J Cancer 111:868-72 CrossRef
  24. Kostadima L, Pentheroudakis G, Pavlidis N (2007) The missing kiss of life: transcriptional activity of the metastasis suppressor gene KISS1 in early breast cancer. Anticancer Res 27:2499-504
  25. Prentice, LM, Klausen, C, Kalloger, S, K?bel M, McKinney S, Santos JL, et al (2007) Kisspeptin and GPR54 immunoreactivity in a cohort of 518 patients defines favourable prognosis and clear cell subtype in ovarian carcinoma. BMC Med 5:33
  26. Lee JH, Miele ME, Hicks DJ, Phillips KK, Trent JM, Weissman BE, Welch DR (1996) KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. J Natl Cancer Inst 88:1731-737 CrossRef
  27. Lee JH, Welch DR (1997) Suppression of metastasis in human breast carcinoma MDA-MB-435 cells after transfection with the metastasis suppressor gene, KiSS-1. Cancer Res 57:2384-387
  
• 作者单位：Lacey R. McNally (1)
  Danny R. Welch (10) (11) (2) (3) (4) (7) (9)
  Benjamin H. Beck (2)
  Lewis J. Stafford (2)
  Joshua W. Long (5)
  Jeffery C. Sellers (1)
  Zhi Q. Huang (1)
  William E. Grizzle (2) (7) (8) (9)
  Cecil R. Stockard (2)
  Kevin T. Nash (2)
  Donald J. Buchsbaum (1) (10) (2) (4) (5) (6) (7)
  
  1. Department of Radiation Oncology, University of Alabama at Birmingham, 1825 University Blvd, Shelby 701, Birmingham, AL, 35294-2182, USA
  10. Gene Therapy Center, University of Alabama at Birmingham, Birmingham, AL, 35294, USA
  11. National Foundation for Cancer Research-Center for Metastasis Research, University of Alabama at Birmingham, Birmingham, AL, 35294, USA
  2. Department of Pathology, University of Alabama at Birmingham, 1670 University Blvd. VH-G019, Birmingham, AL, 35294-0019, USA
  3. Department of Cell Biology, University of Alabama at Birmingham, Birmingham, AL, 35294, USA
  4. Department of Pharmacology & Toxicology, University of Alabama at Birmingham, Birmingham, AL, 35294, USA
  7. Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, 35294, USA
  9. Metabolic Bone Disease Research Center, University of Alabama at Birmingham, Birmingham, AL, 35294, USA
  5. Department of Surgery, University of Alabama at Birmingham, Birmingham, AL, 35294, USA
  8. Center for Aging, University of Alabama at Birmingham, Birmingham, AL, 35294, USA
  6. Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, AL, 35294, USA
  
• ISSN：1573-7276

文摘

Identifying molecular targets for treatment of pancreatic cancer metastasis is critical due to the high frequency of dissemination prior to diagnosis of this lethal disease. Because the KISS1 metastasis suppressor is expressed at reduced levels in advanced pancreatic cancer, we hypothesized that re-expression of KISS1 would reduce metastases. Highly metastatic S2VP10 cells expressing luciferase (S2VP10L) were transfected with a FLAG-tagged version of KISS1 (KFM), KFMΔSS (with deleted secretion signal sequence), or pcDNA3 control plasmid (CP) and expression was confirmed by RTQ-PCR. SCID mice were implanted orthotopically with S2VP10L cells or transfectants and tumor growth and metastases were monitored using bioluminescence imaging. Mice with S2VP10L-KISS1 tumors developed fewer liver (98%) and lung (99%) metastases than S2VP10L. Unexpectedly, mice with S2VP10L-KFMΔSS tumors also had reduced liver and lung metastases, but had more metastases than mice with S2VP10L-KISS. KISS1 protein was found in the cytoplasm of both KFMΔSS and KISS1-expressing orthotopic tumors by immunohistochemistry. Metastases were not found in lungs of mice with S2VP10L-KISS1 tumors; whereas, KFMΔSS lung sections had regions of concentrated KISS1 staining, suggesting that secretion of KISS1 is needed to reduce metastasis significantly. These data suggest induction of KISS1 expression has potential as an adjuvant treatment for pancreatic cancer.